RETRACTED: French ccAFU guidelines - Update 2018-2020: Management of kidney cancer (Retracted Article)

被引：12
作者：
Bensalah, K. [1 ,2 ]
Albiges, L. [1 ,3 ]
Bernhard, J-C [1 ,4 ]
Bigot, P. [1 ,5 ]
Bodin, T. [1 ,6 ]
Boissier, R. [1 ,7 ]
Correas, J-M [1 ,8 ]
Gimel, P. [1 ,9 ]
Hetet, J-F [1 ,10 ]
Long, J-A [1 ,11 ]
Nouhaud, F-X [1 ,12 ]
Ouzaid, I [1 ,13 ]
Rioux-Leclercq, N. [1 ,14 ]
Mejean, A. [1 ,15 ]
机构：
[1] Comite Cancerol Assoc Francaise Urol, Grp Rein, Maison Urol, 11 Rue Viete, F-75017 Paris, France
[2] CHU Rennes, Hop Pontchaillou, Serv Urol, 2 Rue Henri Le Guilloux, F-35033 Rennes, France
[3] Gustave Roussy, Dept Oncol Genito Urinaire, F-94805 Villejuif, France
[4] CHU Bordeaux, Serv Urol & Transplantat Renale, Pl Amelie Raba Leon, F-33076 Bordeaux, France
[5] CHU Angers, Serv Urol, 4 Rue Larrey, F-49000 Angers, France
[6] Ctr Urol Prado Louvain, 188 Rue Rouet, F-13008 Marseille, France
[7] CHU Concept, Serv Urol & Transplantat Renale, 147 Blvd Bailie, F-13005 Marseille, France
[8] Hop Univ Necker Enfants Malades, Serv Imagerie Med Radiol, 149 Rrue Sevres, F-75015 Paris, France
[9] Ctr Urol, Site Medipole,5 Ave Ambroise Croizat, F-66330 Cabestany, France
[10] Clin Jules Verne, Serv Chirurg Urol, 2-4 Route Paris, F-44314 Nantes, France
[11] CHU Grenoble, Hop Michallon, Serv Chirurg Urol & Transplantat Renale, Blvd Chantourne, F-38700 La Tronche, France
[12] CHU Rouen, Serv Urol, 1 Rue Germont, F-76000 Rouen, France
[13] Hop Bichat Claude Bernard, Clin Urol, 46 Rue Henri Huchard, F-75018 Paris, France
[14] CHU Pontchaillou, Serv Anat & Cytol Pathol, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France
[15] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Urol, F-75015 Paris, France
来源：
PROGRES EN UROLOGIE | 2018年 / 28卷 / 12期
关键词：
Kidney cancer; Classification; Surgery; Targeted therapy; RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; OPEN RADICAL NEPHRECTOMY; LYMPH-NODE DISSECTION; PERCUTANEOUS RADIOFREQUENCY ABLATION; LAPAROSCOPIC PARTIAL NEPHRECTOMY; INTEGRATED STAGING SYSTEM; QUALITY-OF-LIFE; POSTOPERATIVE PROGNOSTIC NOMOGRAM; PHASE-III TRIAL;
D O I：
10.1016/j.purol.2018.09.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Objective. - To update the French guidelines on kidney cancer. Methods. - A systematic review of the literature between 2015 and 2018 was performed. The most relevant articles regarding the diagnosis, the classification, surgical treatment, medical treatment and follow-up of kidney cancer were retrieved and included in the new guidelines. The guidelines were updated with corresponding levels of evidence. Results. - Thoraco-abdominal CT scan with injection is the best radiological exam for the diagnosis of kidney cancer. MRI and contrast ultrasound can be useful in some cases. Percutaneous biopsy is recommended when histological results will affect clinical decision. Renal tumours must be classified according to pTNM 2017 classification and ISUP grade. Metastatic kidney cancers must be classified according to IMDC criteria. Partial nephrectomy is the recommended treatment for T1a tumours and can be done through an open, laparoscopic or robotic access. T1b tumours can be treated by partial or total nephrectomy according to tumour complexity. Radical nephrectomy is the recommended treatment of advanced localized tumours. In metastatic patients: cytoreductive nephrectomy is recommended in case of good prognosis; medical treatment must be offered first in case of intermediate or bad prognosis. Surgical or local treatment of metastases should be considered in case of solitary lesion or oligo-metastases. First-line recommended drugs in metastatic patients include sunitinib, pazopanib, and the association nivolumab/ipilimumab. Cabozantinib can be offered in option in intermediate and bad prognostic patients. Cystic tumours must be classified according to Bosniak Classification. Surgical excision should be offered to patients with Bosniak III and IV lesions. It is recommended to follow patients clinically and with imaging according to tumour aggressiveness. Conclusion. - These updated recommendations should assist French speaking urologists for their management of kidney cancers. (C) 2018 Published by Elsevier Masson SAS.
引用
收藏
页码：S3 / S31
页数：29
相关论文
共 222 条
[1]   Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI [J].
Adams, Lisa C. ;
Ralla, Bernhard ;
Bender, Yi-Na Y. ;
Bressem, Keno ;
Hamm, Bernd ;
Busch, Jonas ;
Fuller, Florian ;
Makowski, Marcus R. .
CANCER IMAGING, 2018, 18
[2]  
Ahmed M, 2014, RADIOLOGY, V273, P241, DOI [10.1148/radiol.14132958, 10.1016/j.jvir.2014.08.027]
[3]   Survival After Complete Surgical Resection of Multiple Metastases From Renal Cell Carcinoma [J].
Alt, Angela L. ;
Boorjian, Stephen A. ;
Lohse, Christine M. ;
Costello, Brian A. ;
Leibovich, Bradley C. ;
Blute, Michael L. .
CANCER, 2011, 117 (13) :2873-2882
[4]   Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes [J].
An, Julie Y. ;
Ball, Mark W. ;
Gorin, Michael A. ;
Hong, Jiwon J. ;
Johnson, Michael H. ;
Pavlovich, Christian P. ;
Allaf, Mohamad E. ;
Pierorazio, Phillip M. .
UROLOGY, 2017, 100 :151-157
[5]  
[Anonymous], WHO CLASS TUM UR SYS
[6]  
[Anonymous], 2017, TNM CLASSIFICATION M
[7]   The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol [J].
Antonelli, Alessandro ;
Cozzoli, Alberto ;
Zani, Danilo ;
Zanotelli, Tiziano ;
Nicolai, Maria ;
Cunico, Sergio Cosciani ;
Simeone, Claudio .
BJU INTERNATIONAL, 2007, 99 (02) :296-300
[8]   Renal carcinomas with the t(6;11)(p21;q12) -: Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR [J].
Argani, P ;
Laé, M ;
Hutchinson, B ;
Reuter, VE ;
Collins, MH ;
Perentesis, J ;
Tomaszewski, JE ;
Brooks, JSJ ;
Acs, G ;
Bridge, JA ;
Vargas, SO ;
Davis, IJ ;
Fisher, DE ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (02) :230-240
[9]   PRCC-TFE3 renal carcinomas -: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21) [J].
Argani, P ;
Antonescu, CR ;
Couturier, J ;
Fournet, JC ;
Sciot, R ;
Debiec-Rychter, M ;
Hutchinson, B ;
Reuter, VE ;
Boccon-Gibod, L ;
Timmons, C ;
Hafez, N ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1553-1566
[10]   TFEB-amplified Renal Cell Carcinomas An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity [J].
Argani, Pedram ;
Reuter, Victor E. ;
Zhang, Lei ;
Sung, Yun-Shao ;
Ning, Yi ;
Epstein, Jonathan I. ;
Netto, George J. ;
Antonescu, Cristina R. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (11) :1484-1495
12345678910